These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6640057)

  • 21. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A; Krachmalnicoff A; Mannucci PM
    Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A kinetic study on the effects of anticoagulants on the interaction of fibrinogen and thrombin.
    Nakanishi E; Sato H; Nakajima A
    J Biomed Mater Res; 1987 Feb; 21(2):187-200. PubMed ID: 2434508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of antithrombin III with preadsorbed albumin-heparin conjugates.
    Hennink WE; Ebert CD; Kim SW; Breemhaar W; Bantjes A; Feijen J
    Biomaterials; 1984 Sep; 5(5):264-8. PubMed ID: 6487709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reaction of thrombins with human antithrombin III. I. Enzyme activity losses unrelated to the inhibitory reaction and their prevention.
    Latallo ZS; Hall JA
    Thromb Res; 1986 Sep; 43(5):507-21. PubMed ID: 3750277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutral styrene divinylbenzene copolymers for adsorption of toxins in liver failure.
    Weber V; Linsberger I; Hauner M; Leistner A; Leistner A; Falkenhagen D
    Biomacromolecules; 2008 Apr; 9(4):1322-8. PubMed ID: 18345636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulant hydrogels derived from crosslinked dextran. Part II: Mechanism of thrombin inactivation.
    Aubert N; Mauzac M; Gulino D; Jozefonvicz J
    Biomaterials; 1987 Mar; 8(2):100-4. PubMed ID: 2437972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium inhibits the heparin-catalyzed antithrombin III/thrombin reaction by decreasing the apparent binding affinity of heparin for thrombin.
    Speight MO; Griffith MJ
    Arch Biochem Biophys; 1983 Sep; 225(2):958-63. PubMed ID: 6625618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of anticoagulant effects of some sulphated polysaccharides.
    Andersson LO; Hoffman J; Holmer E; Larm O; Larsson K; Söderström G
    Thromb Res; 1982 Dec; 28(6):741-7. PubMed ID: 6132465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of different ions on the interactions of heparin with bovine antithrombin III and thrombin.
    Oshima G; Nagasawa K
    Thromb Res; 1986 May; 42(3):375-82. PubMed ID: 3715809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulant activity of dextran derivatives. Part II: Mechanism of thrombin inactivation.
    Fischer AM; Mauzac M; Tapon-Bretaudiere J; Jozefonvicz J
    Biomaterials; 1985 May; 6(3):198-202. PubMed ID: 2408688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Permeability of a heparin-polyvinyl alcohol hydrogel to thrombin and antithrombin III.
    Smith BA; Sefton MV
    J Biomed Mater Res; 1988 Aug; 22(8):673-85. PubMed ID: 3215905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.
    Griffith MJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5460-4. PubMed ID: 6577437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of antithrombin III and thrombin to immobilized heparin under flow conditions.
    Byun Y; Jacobs HA; Kim SW
    Biotechnol Prog; 1996; 12(2):217-25. PubMed ID: 8857192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affinity chromatography of thrombin on modified polystyrene resins.
    Yu XJ; Fischer AM; Muller D; Bros A; Tapon-Bretaudiere J; Jozefonvicz J
    J Chromatogr; 1986 Apr; 376():429-35. PubMed ID: 3711199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anticoagulant properties of mast cell product, chondroitin sulphate E.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem Biophys Res Commun; 1986 May; 137(1):15-22. PubMed ID: 3087353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor.
    Danishefsky I; Tzeng F; Ahrens M; Klein S
    Thromb Res; 1976 Feb; 8(2):131-40. PubMed ID: 56053
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction of antithrombin III and thrombin-antithrombin III complex with cultured aortic endothelial cells.
    Bartha K; Kovács T; Léránt I; Papp B; Csonka E; Kolev K; Machovich R
    Thromb Res; 1987 Sep; 47(5):541-52. PubMed ID: 3672436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the molecular mass dependency of heparin stimulation of heparin cofactor II:thrombin interaction to antithrombin III:thrombin interaction.
    Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1987 May; 46(3):491-502. PubMed ID: 3603437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.